{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:55:49Z","timestamp":1787320549493,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejogrb.2024.02.011","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T11:10:35Z","timestamp":1707563435000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Distribution and anthropometric characteristics of Rotterdam criteria-based phenotypic forms of Polycystic ovaries syndrome in Ukraine"],"prefix":"10.1016","volume":"295","author":[{"given":"Tetiana","family":"Tatarchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pedachenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Kosei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Malysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Snizhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Kozub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Zolotarevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Kosianenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Tutchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejogrb.2024.02.011_b0005","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.02.011_b0010","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil Steril"},{"issue":"279","key":"10.1016\/j.ejogrb.2024.02.011_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2022.10.020","article-title":"Prevalence of polycystic ovary syndrome in European countries and USA: a systematic review and meta-analysis","volume":"1","author":"Chiaffarino","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0020","doi-asserted-by":"crossref","unstructured":"Hoyos LR, Putra Ma, Armstrong AA, Cheng CY, Riestenberg CK, Schooler TA, et al. Measures of Patient Dissatisfaction With Health Care in Polycystic Ovary Syndrome: Retrospective Analysis. J Med Internet Res 2020;22(4)e16541 https\/\/www.jmir.org\/2020\/4\/e16541. 2020 Apr 21;22(4):e16541.","DOI":"10.2196\/16541"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.02.011_b0025","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020\u2021","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.02.011_b0030","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.02.011_b0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/jcm9030732","article-title":"Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes","volume":"9","author":"Polak","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0045","doi-asserted-by":"crossref","unstructured":"Gupta M, Yadav R, Mahey R, Agrawal A, Upadhyay A, Malhotra N, et al. Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes \u2013 a cross-sectional study. https:\/\/doi.org\/101080\/0951359020191613640. 2019 Nov 2;35(11):970\u20133.","DOI":"10.1080\/09513590.2019.1613640"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.02.011_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3464","article-title":"Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome","volume":"38","author":"Krentowska","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.02.011_b0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","article-title":"Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"111","author":"Zhu","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0060","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.103808","article-title":"Special considerations on hyperandrogenism and insulin resistance in nonobese polycystic ovaries syndrome","author":"Tatarchuk","year":"2022","journal-title":"Polycystic Ovary Syndr - Funct Investig Clin Appl"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/diagnostics12102313","article-title":"Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the rotterdam phenotype in influencing the metabolic status","volume":"12","author":"Carmina","year":"2022","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.02.011_b0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.rbmo.2020.12.006","article-title":"Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review","volume":"42","author":"Sendur","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.02.011_b0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.02.011_b0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/jhrs.JHRS_34_20","article-title":"Divergences in clinical, anthropometric, metabolic, and hormonal parameters among different phenotypes of polycystic ovary syndrome presenting at endocrinology outpatient departments: a multicenter study from Bangladesh","volume":"13","author":"Kamrul-Hasan","year":"2020","journal-title":"J Hum Reprod Sci"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.02.011_b0085","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/humrep\/dez185","article-title":"Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource","volume":"34","author":"Azziz","year":"2019","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.02.011_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.genm.2010.04.002","article-title":"Hirsutism: Diagnosis and management","volume":"7","author":"Brodell","year":"2010","journal-title":"Gend Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.02.011_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.02.011_b0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1933719114522525","article-title":"Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: An assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome","volume":"21","author":"Clark","year":"2014","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.02.011_b0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0974-1208.121422","article-title":"Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: a prospective study of PCOS women","volume":"6","author":"Kar","year":"2013","journal-title":"J Hum Reprod Sci"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.02.011_b0110","first-page":"604","volume":"23","author":"Pehlivanov","year":"2009","journal-title":"Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.02.011_b0115","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population","volume":"116","author":"Zhang","year":"2009","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.02.011_b0120","first-page":"763","article-title":"The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females","volume":"16","author":"Mehrabian","year":"2011","journal-title":"J Res Med Sci"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.02.011_b0125","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.02.011_b0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.02.011_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cen.14402","article-title":"Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS)","volume":"95","author":"Phylactou","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0140","doi-asserted-by":"crossref","unstructured":"Anastasiou OE, Canbay A, Fuhrer D, Reger-Tan S. Metabolic and androgen profile in underweight women with polycystic ovary syndrome. Arch Gynecol Obstet 2017 2962. 2017 Jun 12;296(2):363\u201371.","DOI":"10.1007\/s00404-017-4422-9"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.02.011_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvac003","article-title":"Female adult acne and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee","volume":"6","author":"Carmina","year":"2022","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.02.011_b0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coemr.2020.02.015","article-title":"Cutaneous manifestations of polycystic ovary syndrome","volume":"1","author":"Carmina","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.02.011_b0155","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2022.01.014","article-title":"Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study","volume":"117","author":"van Keizerswaard","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.02.011_b0160","doi-asserted-by":"crossref","unstructured":"Gleicher N, Darmon S, Patrizio P, Barad DH. Reconsidering the Polycystic Ovary Syndrome (PCOS). Biomed 2022, Vol 10, Page 1505. 2022 Jun 25;10(7):1505.","DOI":"10.3390\/biomedicines10071505"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.02.011_b0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/biomedicines11010096","article-title":"Hyperandrogenic symptoms are a persistent suffering in midlife women with PCOS; a prospective cohort study in Sweden","volume":"11","author":"Persson","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.02.011_b0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.steroids.2013.04.005","article-title":"Changes in the PCOS phenotype with age","volume":"78","author":"Hsu","year":"2013","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.02.011_b0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:03:43Z","timestamp":1759557823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S0301211524000599"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.02.011","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution and anthropometric characteristics of Rotterdam criteria-based phenotypic forms of Polycystic ovaries syndrome in Ukraine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}